These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2019335)
21. Vitamin E reduces accumulation of amiodarone and desethylamiodarone and inhibits phospholipidosis in cultured human cells. Honegger UE; Scuntaro I; Wiesmann UN Biochem Pharmacol; 1995 Jun; 49(12):1741-5. PubMed ID: 7598736 [TBL] [Abstract][Full Text] [Related]
22. Cytotoxic interaction between amiodarone and desethylamiodarone in human peripheral lung epithelial cells. Roth FC; Mulder JE; Brien JF; Takahashi T; Massey TE Chem Biol Interact; 2013 Aug; 204(3):135-9. PubMed ID: 23707191 [TBL] [Abstract][Full Text] [Related]
23. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms. Shayeganpour A; El-Kadi AO; Brocks DR Drug Metab Dispos; 2006 Jan; 34(1):43-50. PubMed ID: 16204463 [TBL] [Abstract][Full Text] [Related]
24. Effects of amiodarone administration during lactation in Fischer-344 rats. Hill DA; Reasor MJ Toxicol Lett; 1992 Sep; 62(2-3):119-25. PubMed ID: 1412498 [TBL] [Abstract][Full Text] [Related]
25. Tissue distribution of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone dosages. Plomp TA; Wiersinga WM; Maes RA Arzneimittelforschung; 1985; 35(1):122-9. PubMed ID: 4039141 [TBL] [Abstract][Full Text] [Related]
26. Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats. Morvay N; Baczkó I; Sztojkov-Ivanov A; Falkay G; Papp JG; Varró A; Leprán I Can J Physiol Pharmacol; 2015 Sep; 93(9):773-7. PubMed ID: 26176275 [TBL] [Abstract][Full Text] [Related]
27. Effects of vitamin E on cytotoxicity of amiodarone and N-desethylamiodarone in isolated hamster lung cells. Bolt MW; Racz WJ; Brien JF; Massey TE Toxicology; 2001 Sep; 166(3):109-18. PubMed ID: 11543907 [TBL] [Abstract][Full Text] [Related]
28. Disruption of mitochondrial function and cellular ATP levels by amiodarone and N-desethylamiodarone in initiation of amiodarone-induced pulmonary cytotoxicity. Bolt MW; Card JW; Racz WJ; Brien JF; Massey TE J Pharmacol Exp Ther; 2001 Sep; 298(3):1280-9. PubMed ID: 11504831 [TBL] [Abstract][Full Text] [Related]
29. Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats. Hostetler KY; Reasor MJ; Walker ER; Yazaki PJ; Frazee BW Biochim Biophys Acta; 1986 Feb; 875(2):400-5. PubMed ID: 3942773 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after intravenous administration. Plomp TA; Wiersinga WM; van Rossum JM; Maes RA In Vivo; 1989; 3(1):33-47. PubMed ID: 2519831 [TBL] [Abstract][Full Text] [Related]
31. The effect of CYP1A induction on amiodarone disposition in the rat. Elsherbiny ME; Brocks DR J Pharm Sci; 2010 Jan; 99(1):539-48. PubMed ID: 19718765 [TBL] [Abstract][Full Text] [Related]
33. Cellular accumulation of amiodarone and desethylamiodarone in cultured human cells. Consequences of drug accumulation on cellular lipid metabolism and plasma membrane properties of chronically exposed cells. Honegger UE; Zuehlke RD; Scuntaro I; Schaefer MH; Toplak H; Wiesmann UN Biochem Pharmacol; 1993 Jan; 45(2):349-56. PubMed ID: 8382061 [TBL] [Abstract][Full Text] [Related]
34. Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages. Plomp TA; Wiersinga WM; Maes RA Arzneimittelforschung; 1985; 35(12):1805-10. PubMed ID: 4096733 [TBL] [Abstract][Full Text] [Related]
35. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens. Brien JF; Jimmo S; Brennan FJ; Armstrong PW; Abdollah H Drug Metab Dispos; 1990; 18(6):846-51. PubMed ID: 1981527 [TBL] [Abstract][Full Text] [Related]
36. Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues. Brien JF; Jimmo S; Brennan FJ; Ford SE; Armstrong PW Can J Physiol Pharmacol; 1987 Mar; 65(3):360-4. PubMed ID: 3580958 [TBL] [Abstract][Full Text] [Related]
37. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects. Martin WJ; Standing JE J Pharmacol Exp Ther; 1988 Feb; 244(2):774-9. PubMed ID: 3346847 [TBL] [Abstract][Full Text] [Related]
38. Effect of amiodarone on phospholipid content and composition in heart, lung, kidney and skeletal muscle: relationship to alteration of thyroid function. Rabkin SW Pharmacology; 2006; 76(3):129-35. PubMed ID: 16401913 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms of amiodarone and desethylamiodarone cytotoxicity in nontransformed human peripheral lung epithelial cells. Mulder JE; Brien JF; Racz WJ; Takahashi T; Massey TE J Pharmacol Exp Ther; 2011 Feb; 336(2):551-9. PubMed ID: 21078785 [TBL] [Abstract][Full Text] [Related]
40. Presynaptic antisympathetic action of amiodarone and its metabolite desethylamiodarone. Haikerwal D; Du XJ; Turner A; Esler MD; Dart AM J Cardiovasc Pharmacol; 1999 Feb; 33(2):309-15. PubMed ID: 10028942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]